Current Issue

Application of Quality Risk Management to Process Validation

Robert Dream, Managing Director, HDR Company LLC

A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization

Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...

Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...

Ping Wang, Director, Johnson & Johnson

Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics

Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...

Amsphere A3

JSR Life Sciences



Headline News

FDA expands TALZENNA plus XTANDI approval to earlier metastatic prostate cancer setting


Jemperli achieves 76% complete response rate in Phase II rectal cancer trial


Ris-Rez cuts progression risk by 67% in Phase III relapsed osteosarcoma trial


Read All Headlines

Upcoming Webinars

View All Upcoming Webinars

Past Webinars

Mass Spectrometry – an Essential Tool for Characterization of Monoclonal Antibodies during Development

Presented by Dr Wei Xu & Dr Henry Shion
03rd February 2016


The Journey to Lean Implementation for Efficiency Increase

Presented by Uwe Voelker, Site Head, Sterile Drug Product Manufacturing at Roche
04th September 2019


Changing the Paradigm: Moving to In-Process Release Testing

Presented by Presented by Scott Weiss, Director, Industrial Microbiology at Johnson & Johnson and Lori Daane, Pharma Microbiology Scientific Director at bioMérieux
05th February 2021


View All Past Webinars

Featured Companies

 

View All Companies

© 2026 biopharma-asia.com. All rights reserved. Privacy Policy

Biopharma Asia